Crowdfunding
Lemonaid Offers Shares to Consumers for the First Time
Lemonaid Beverages will offer shares to consumers for the first time from July 6, 2026, through GLS Crowd and Wiwin. Priced at €39.90, the registered shares include voting rights. The company, founded in 2009, focuses on organic and fair trade drinks, operates in over 30 countries, and supports social projects.
Starting July 6th, 2026, beverage manufacturer Lemonaid Beverages will offer shares for purchase for the first time. Subscriptions will be processed through the GLS Crowd and Wiwin platforms, according to the company. The move will allow consumers to directly participate in the company’s development.
Lemonaid Offers Shares to Consumers for the First Time
One share will cost €39.90 and will be issued as a registered share with full voting rights. Lemonaid is deliberately choosing not to pursue a traditional IPO, instead aiming to make company participation accessible to a broader group of people.
“With a Lemonaid share, you not only acquire a stake in the company, but also underline your conviction that economic success and social impact go hand in hand,” said founder Paul Bethke.
Organic Beverages Available in More Than 30 Countries
Lemonaid was founded in 2009 and produces beverages made with organic and fair trade ingredients. Since its launch, the company has sold several hundred million bottles of its Lemonaid and Charitea brands.
According to the company, revenue has increased by an average of 39 percent annually over a period of 17 years. Lemonaid products are now available in more than 30 countries.
The company emphasizes that its business model combines commercial growth with social goals. Through its activities, Lemonaid states that it has raised more than €13 million for social projects in growing regions.
Focus on Social Impact
Lemonaid highlights several initiatives from its history, including its campaign against legally required minimum sugar content regulations for lemonade. The company also states that it helped establish corporate sponsorship of social institutions.
With the share offering, Lemonaid aims to give consumers the opportunity to become directly involved in the company while supporting its approach of combining business success with social impact. The shares will provide investors with voting rights and a direct stake in the beverage manufacturer.
—
(Featured image by Nahima Aparicio via Unsplash)
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in Lebensmittel Praxis. A third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
-
Cannabis1 week agoYouth Cannabis Use in Colorado Is Falling — But the Full Story Is More Complex
-
Impact Investing2 weeks agoEU Weighs More Free Emission Permits in ETS Review to Boost Industry Competitiveness
-
Markets1 day agoMarkets on Borrowed Time Amid Economic Cracks and Global Uncertainty
-
Biotech2 weeks agoGilead HSV Plan Could Transform Market Outlook



